Bruker Corporation (BRKR) is a publicly traded Healthcare sector company. As of July 5, 2026, BRKR trades at $61.64 with a market cap of $9.38B and a P/E ratio of -256.83. BRKR moved +1.67% today. Year to date, BRKR is +29.74%; over the trailing twelve months it is +45.17%. Its 52-week range spans $28.53 to $64.64. Analyst consensus is buy with an average price target of $52.38. Rallies surfaces BRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BRKR shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $61.64 |
| Market Cap | $9.38B |
| P/E Ratio | -256.83 |
| EPS | $-0.24 |
| Dividend Yield | 0.05% |
| 52-Week High | $64.64 |
| 52-Week Low | $28.53 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.46B |
| Net Income | $-9.40M |
| Gross Margin | 45.29% |
9 analysts cover BRKR: 0 strong buy, 4 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $52.38.